TCRG4.1-transduced CD8+ T cells mediated comparable levels of tumour killing against a second GBM cell line, GBM102, and two melanoma cell lines, RPMI-7951 and WM-266-4 (Extended Data Fig. 10a). This evidence concerns the gene CD8A and glioblastoma.